|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0007131,
umls-concept:C0024432,
umls-concept:C0038952,
umls-concept:C0039194,
umls-concept:C0085358,
umls-concept:C0332448,
umls-concept:C0441772,
umls-concept:C0750502,
umls-concept:C1332717,
umls-concept:C1413244,
umls-concept:C1706438,
umls-concept:C2698600,
umls-concept:C2698872
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-9-15
|
|
pubmed:abstractText |
The purpose of this study was to investigate whether tumor-infiltrating immune cells in biopsy specimens can be used to predict the clinical outcome of stage IV nonsmall cell lung cancer (NSCLC) patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
pubmed-author:AokageKeijuK,
pubmed-author:GemmaAkihikoA,
pubmed-author:IshiiGenichiroG,
pubmed-author:KawaiOsamuO,
pubmed-author:KubotaKaoruK,
pubmed-author:KudohSyojiS,
pubmed-author:MizunoTetsuyaT,
pubmed-author:MurataYukinoriY,
pubmed-author:NaitoYoichiY,
pubmed-author:NishiwakiYutakaY,
pubmed-author:OchiaiAtsushiA,
pubmed-author:SaijoNagahiroN
|
|
pubmed:copyrightInfo |
(c) 2008 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
113
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1387-95
|
|
pubmed:meshHeading |
pubmed-meshheading:18671239-Adenocarcinoma,
pubmed-meshheading:18671239-Adult,
pubmed-meshheading:18671239-Aged,
pubmed-meshheading:18671239-Antigens, CD,
pubmed-meshheading:18671239-Antigens, Differentiation, Myelomonocytic,
pubmed-meshheading:18671239-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18671239-CD8-Positive T-Lymphocytes,
pubmed-meshheading:18671239-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18671239-Carcinoma, Squamous Cell,
pubmed-meshheading:18671239-Female,
pubmed-meshheading:18671239-Humans,
pubmed-meshheading:18671239-Lung Neoplasms,
pubmed-meshheading:18671239-Lymphocyte Activation,
pubmed-meshheading:18671239-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:18671239-Macrophages,
pubmed-meshheading:18671239-Male,
pubmed-meshheading:18671239-Mast Cells,
pubmed-meshheading:18671239-Middle Aged,
pubmed-meshheading:18671239-Neoplasm Staging,
pubmed-meshheading:18671239-Prognosis,
pubmed-meshheading:18671239-Stromal Cells,
pubmed-meshheading:18671239-Survival Rate
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
|
|
pubmed:affiliation |
Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
